Scott D. Barnes - 21 May 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: Chief Medical Officer
Signature: /s/ Samuel Gesten as attorney-in-fact for Scott Barnes
Issuer symbol: STAA
Transactions as of: 21 May 2021
Net transactions value: -$1,220,918
Form type: 4
Filing time: 21 May 2021, 16:05:53 UTC
Next filing: 08 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Options Exercise	$40,375	+2,500	+11%	$16.15	25,826	21 May 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$80,199	+2,229	+8.6%	$35.98	28,055	21 May 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$208,292	+7,566	+27%	$27.53	35,621	21 May 2021	Direct
transaction	STAA	Common Stock	Disposed to Issuer	$1,549,785	-12,295	-35%	$126.05	23,326	21 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Common Stock Options	Options Exercise	$0	-2,500	-32%	$0.000000	5,200	21 May 2021	Common Stock	2,500	$16.15	Direct
transaction	STAA	Common Stock Options	Options Exercise	$0	-2,229	-20%	$0.000000	9,157	21 May 2021	Common Stock	2,229	$35.98	Direct	F2
transaction	STAA	Common Stock Options	Options Exercise	$0	-7,566	-39%	$0.000000	11,891	21 May 2021	Common Stock	7,566	$27.53	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.00 to $126.36, inclusive.
F2	The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
F3	The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.